Source: Owler

Nabriva Therapeutics plc: Nabriva's revenue changed from $35.62M in Sep 2022 to $36.94M in Dec 2022

Nabriva’s Trailing Twelve Months revenue changed from $35.62M in Sep 2022 to $36.94M in Dec 2022 increasing 3.7% in this time period.

Read full article »
Nabriva Therapeutics plc's Competitors | Nabriva Therapeutics plc's News | Nabriva Therapeutics plc's Financials
Stay up-to-date with the latest news on Nabriva
Annual Revenue
$25-100M
Employees
100-250
Ted Schroeder's photo - CEO of Nabriva

CEO

Ted Schroeder

CEO Approval Rating

89/100

Read more
Stay up-to-date with the latest news on Nabriva